Telomir Pharmaceuticals Sells $500K in Stock
Ticker: TELO · Form: 8-K · Filed: Dec 11, 2024 · CIK: 1971532
Sentiment: neutral
Topics: unregistered-sale, equity-offering, capital-raise
TL;DR
Telomir just sold $500K in stock at $0.50/share, unregistered.
AI Summary
Telomir Pharmaceuticals, Inc. announced on December 9, 2024, that it entered into a securities purchase agreement for the sale of 1,000,000 shares of its common stock at a price of $0.50 per share, for a total of $500,000. This transaction is considered an unregistered sale of equity securities.
Why It Matters
The company is raising capital through an unregistered sale of equity, which could dilute existing shareholders and may indicate a need for immediate funding.
Risk Assessment
Risk Level: medium — The sale of unregistered securities can indicate potential financial distress or a need for quick capital, and it may lead to dilution for existing shareholders.
Key Numbers
- $500,000 — Proceeds from Stock Sale (Capital raised through the sale of common stock.)
- 1,000,000 — Shares Sold (Number of common stock shares sold in the transaction.)
- $0.50 — Price Per Share (The price at which each share of common stock was sold.)
Key Players & Entities
- Telomir Pharmaceuticals, Inc. (company) — Registrant
- December 9, 2024 (date) — Date of earliest event reported
- $500,000 (dollar_amount) — Total proceeds from stock sale
- 1,000,000 (number) — Number of shares sold
- $0.50 (dollar_amount) — Price per share
FAQ
What is the purpose of the unregistered sale of equity securities?
The filing does not explicitly state the purpose of the unregistered sale of equity securities, but it is a common method for companies to raise capital.
Who purchased the 1,000,000 shares of common stock?
The filing does not disclose the identity of the purchasers of the 1,000,000 shares of common stock.
Are there any restrictions on the resale of these shares?
As these are unregistered securities, there are likely resale restrictions under Rule 144 or other exemptions, though the filing does not detail them.
What is the significance of the $0.50 per share price?
The $0.50 per share price represents the agreed-upon valuation for the sale of the company's common stock in this transaction.
Does this transaction require registration with the SEC?
No, this transaction is described as an 'Unregistered Sales of Equity Securities,' indicating it was conducted under an exemption from SEC registration requirements.
Filing Stats: 526 words · 2 min read · ~2 pages · Grade level 13 · Accepted 2024-12-11 16:01:10
Key Financial Figures
- $1 Million — Events Telomir Pharmaceuticals Raises $1 Million at $7 Per Share in a No-Warrant, Restri
- $7 — ir Pharmaceuticals Raises $1 Million at $7 Per Share in a No-Warrant, Restricted C
- $1 m — a price of $7 per share for a total of $1 million, a 20% premium to the closing pri
- $5 million — ny warrants. This transaction follows a $5 million non-dilutive line of credit extended to
Filing Documents
- form8-k.htm (8-K) — 36KB
- 0001493152-24-049630.txt ( ) — 207KB
- telo-20241209.xsd (EX-101.SCH) — 3KB
- telo-20241209_lab.xml (EX-101.LAB) — 33KB
- telo-20241209_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TELOMIR PHARMACUTICALS, INC. Dated: December 11, 2024 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer